Adage Capital Partners’s Opus Genetics IRD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRD
Adage Capital Partners's IRD Position: Q3 2026 in Review
Adage Capital Partners reduced its Opus Genetics (IRD) stake by 63% in Q3 2026, selling an estimated $15.7M and leaving 2,254,996 shares worth $10.9M. The position accounts for 0.02% of the portfolio, ranked #701.
Adage Capital Partners first reported a position in IRD in Q3 2025 and has held it in 5 quarters since. The position peaked at $27.4M in Q1 2026. 91 funds tracked by Wall St. Rank hold IRD as of Q3 2026.
- Adage Capital Partners held 2,254,996 shares of Opus Genetics worth $10.9M as of Q3 2026.
- Adage Capital Partners sold 3,774,779 Opus Genetics shares in Q3 2026, an estimated $15.7M.
- Opus Genetics made up 0.02% of Adage Capital Partners's portfolio in Q3 2026, its #701 holding.
- Adage Capital Partners first reported a position in Opus Genetics in Q3 2025 and has held it in 5 quarters since.
- Adage Capital Partners's Opus Genetics position peaked at $27.4M in Q1 2026.
- 91 funds tracked by Wall St. Rank held Opus Genetics as of Q3 2026.
Based on Adage Capital Partners's 13F filing for Q3 2026, filed 16 Nov 2026.